Login to Your Account

Start-up Kymab Raises $30.1M in First VC Round

By Nuala Moran

Tuesday, July 13, 2010
LONDON – Kymab Ltd. has attracted £20 million (US$30.1 million) in a first round of venture capital funding, to commercialize a new platform for generating antibodies using mice that are engineered to have part-human immune systems. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription